Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-016814
Filing Date
2021-08-12
Accepted
2021-08-12 16:10:53
Documents
54
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q blcm-20210630.htm   iXBRL 10-Q 1369759
2 EX-10.2 a2021-q2exhibit102.htm EX-10.2 136875
3 EX-31.1 a2021q2exhibit311.htm EX-31.1 11802
4 EX-32.1 a2021q2exhibit321.htm EX-32.1 6011
  Complete submission text file 0001628280-21-016814.txt   5801981

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20210630.xsd EX-101.SCH 36849
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20210630_cal.xml EX-101.CAL 49039
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20210630_def.xml EX-101.DEF 202549
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20210630_lab.xml EX-101.LAB 481043
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20210630_pre.xml EX-101.PRE 318699
10 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20210630_htm.xml XML 805332
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

EIN.: 201450200 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36783 | Film No.: 211167639
SIC: 2834 Pharmaceutical Preparations